Oral Microbiota Therapeutic Reduces CDI Recurrence in High-Risk Patients
Researchers investigated the efficacy of an oral microbiota therapeutic against recurrent Clostridioides difficile infection across high-risk subgroups.
Researchers investigated the efficacy of an oral microbiota therapeutic against recurrent Clostridioides difficile infection across high-risk subgroups.
An investigation explored dose-dependent effects of alcohol consumption of type 2 diabetes mellitus and obesity risk.
Investigators assessed the use of different combined oral contraceptive pills for the treatment and management of polycystic ovary syndrome, as an update to recent evidence-based guidelines.
Research on the potential link between vaccines and Guillain-Barre syndrome has mixed findings — some indicate a minimal association; others do not find a significant causal relationship.
Researchers examined the safety and efficacy of several weight loss drugs approved for the management of obesity.
Researchers examined the effects of outpatient treatment with metformin, ivermectin, and fluvoxamine on the risk for long COVID.
Researchers sought to determine the association between COVID-19 diagnoses or deaths and STI incidences for all US counties in 2020.
In a large, population-based case-control study, researchers identified prescription medications associated with a lower risk for 3 neurodegenerative diseases: Parkinson disease, Alzheimer disease, and amyotrophic lateral sclerosis.
In a case-control study, researchers determined whether translocator protein total distribution volume is elevated in the dorsal putamen, ventral striatum, prefrontal cortex, anterior cingulate cortex, and hippocampus of individuals with COVID-DC.
Researchers aimed to evaluate weight change in relation to carbohydrate intake, dietary fiber, total sugars, and sucrose.